Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Epidermal growth factor (EGF) is a small 53 amino acid polypeptide growth factor that stimulates cell growth, proliferation, differentiation, and survival by binding to its receptor EGFR. It plays a key role in the regulation of epithelial cell proliferation and tissue repair processes such as wound healing and maintenance of healthy skin structure and function. Overexpression or dysregulation is implicated in cancer biology.
EGF binds to the plasma membrane-located EGFR, a transmembrane protein tyrosine kinase receptor. Ligand binding induces dimerization of EGFR, activating its intrinsic kinase activity through autophosphorylation on specific tyrosine residues in the cytoplasmic domain. This activates multiple signal transduction pathways including MAPK, PI3K/Akt, and JNK, leading to cellular effects such as DNA synthesis, cellular proliferation/differentiation/survival, migration/adhesion changes, actin cytoskeleton remodeling, angiogenesis promotion, and mucosal protection/healing.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Epidermal Growth Factor.